No takes yet. Share an insight, caveat, or question.
UPLC-LCMS method demonstrates effective impurity profiling and stability analysis of nirogacestat, indicating robustness.
Thrinath et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: